Aggressive natural killer cell lymphoproliferative disorder associated with Epstein-Barr viral RNA

American Journal of Hematology

Volumn 54, Issue 4, 1997, Pages 314-320

  Hirose, Yuko ^a   Masaki, Yasufumi ^a   Yoshioka, Ritsuko ^a   Takiguchi, Tomoo ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Epstein Barr virus encoded RNA 1; In situ hybridization; Lymphoproliferative disorder; Natural killer cell

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CASE REPORT; EPSTEIN BARR VIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LYMPHOPROLIFERATIVE DISEASE; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL;

ADULT; HERPESVIRUS 4, HUMAN; HUMANS; IN SITU HYBRIDIZATION; KILLER CELLS, NATURAL; LYMPHOPROLIFERATIVE DISORDERS; MALE; OLIGONUCLEOTIDES, ANTISENSE; POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 0030940975     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199704)54:4<314::AID-AJH10>3.0.CO;2-B     Document Type: Article

References (27)

1. Timonen T, Ortaldo JR, Herberman RB: Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 153:569-582, 1981.
2. Trinchieri G, Perussia B: Human natural killer cells: Biologic and pathologic aspects. Lab Invest 50:489-513, 1984.
3. Lanier LL, Phillips JH, Hackett J Jr, Tutt M, Kumar V: Natural killer cells: Definition of a cell type rather than a function. J Immunol 137:2735-2739, 1986.
4. Loughran TP, Jr: Clonal diseases of large granular lymphocytes. Blood 82:1-14, 1993.
5. Kawa-Ha K, Ishihara S, Ninomiya T, Yumura-Yagi K, Hara J, Murayama F, Tawa A, Hirai K: CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J Clin Invest 84:51-55, 1989.
6. Hart DNJ, Baker BW, Inglis MJ, Nimmo JC, Starling GC, Deacon E, Rowe M, Beard MEJ: Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells. Blood 79:2116-2123, 1992.
7. Winchester RJ, Ross G: Methods for enumerating lymphocyte population. In Rose NR, Friedman H (eds): "Manual of Clinical Immunology." Washington, DC: American Society for Microbiology, 1976, pp 64-76.
8. Shimizu S, Sugai S, Konda S, Yamanaka Y, Setoyama M: A monoclonal surface immunoglobulin (IgM/D-L) with specificity for surface antigen of ox red blood cells in a patient with leukemic lymphosarcoma. J Clin Immunol 6:397-401, 1986.
9. Young LS, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, Rowe DT, Greenspa D, Greenspan JS, Rickinson AB, Farrel PJ: Differentiation-associated expression of Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 65:2868-2874, 1991.
10. Brousset P, Butet V, Chittal S, Selves J, Delsol G: Comparison of in situ hybridization using different nonisotopic probes for detection of Epstein-Barr virus in nasopharyngeal carcinoma and immunohistochemical correlation with anti-latent membrane protein antibody. Lab Invest 67:457-464, 1992.
11. Shihata D, Weiss LM, Nathwani BN, Brynes RK, Levine AM: Epstein-Barr virus in benign lymph node biopsies from individuals infected with the human immunodeficiency virus is associated with concurrent or subsequent development of non-Hodgkin's lymphoma. Blood 77:1527-1533, 1991
12. Hennesy K, Fennewald S, Hummel M, Cole T, Kieff E: A membrane protein encoded by Epstein-Barr virus in latent growth-transforming infection. Proc Natl Acad Sci USA 81:7207-7211, 1984.
13. Mies C: Molecular pathology of paraffin-embedded tissue. Diagn Mol Pathol 1:206-211, 1992.
14. Chan WC, Link S, Mawle A, Check I, Brynes RK, Winton EF: Heterogeneity of large granular lymphocyte proliferations: Delineation of two major subtypes. Blood 68:1142-1153, 1986.
15. Fernandez LA, Pope B, Lee C, Zayed E: Aggressive natural killer cell leukemia in adult with establishment of an NK cell line. Blood 67:925-930, 1986.
16. Koizumi S, Seki H, Tachinami T, Taniguchi M, Matsuda A, Taga K, Nakarai T, Kato E, Taniguchi N, Nakamura H: Malignant clonal expansion of large granular lymphocytes with a Leu11+, Leu7-surface phenotype: In vitro responsiveness of malignant cells to recombinant human interleukin 2. Blood 68:1065-1073, 1986.
17. Ohno T, Kanoh T, Arita Y, Fujii H, Kuribayashi K, Masuda T, Horiguchi Y, Taniwaki M, Nosaka T, Hatanaka M, Uchino H: Fulminant clonal expansion of large granular lymphocytes. Characterization of their morphology, phenotype, genotype and function. Cancer 62:1918-1927, 1988.
18. Sheridan W, Winton EF, Chan WC, Gordon DS, Vogler R, Phillips C, Bongiovanni KF, Waldmann TA: Leukemia of non-T lineage natural killer cells. Blood 72:1701-1707, 1988.
19. Ohno Y, Amakawa R, Furukawa S, Huang CR, Kamesaki H, Amano H, Imanaka T, Takahashi Y, Arita Y, Uchiyama T, Kita K, Miwa H: Acute transformation of chronic large granular lymphocyte leukemia associated with additional chromosome abnormality. Cancer 64:63-67, 1989.
20. Imamura N, Kusunoki Y, Kawa-Ha K, Yumura K, Hara J, Oda K, Abe K, Dohy H, Inada T, Kajihara H, Kuramoto A: Aggressive natural killer cell leukaemia/lymphoma: Report of four cases and review of the literature. Br J Haematol 75:49-59, 1990.
21. Wong KF, Chan JKC, Lee KC, Cheung MMC: CD56(NKH1)-positive hematolymphoid malignancies: An aggressive neoplasm featuring frequent cutaneous/mucosal involvement, cytoplasmic azurophilic granules, and angiocentricity. Hum Pathol 23:798-804, 1992.
22. Kanavaros P, Lescs M-C, Briere J, Divine M, Galateau F, Joab I, Bosq J, Farcet J-P, Reyes F, Gaulard P: Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and Epstein-Barr virus. Blood 81:2688-2695, 1993.
23. Semenzato G, Pandolf F, Chisesi T, De Rossi G, Pizzolo G, Zambello R, Trentin L, Agostini C, Dini E, Vespignani M, Cafaro A, Pasqualetti D, Giubellino C, Migone N, Foa R: The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions. Cancer 60:2971-2978, 1987.
24. Chan WC, Gu LB, Masih A, Nicholson J, Vogler WR, Yu G, Nasr S: Large granular lymphocyte proliferation with natural killer-cell phenotype. Am J Clin Pathol 97:353-358, 1992.
25. Evans AS, Gutensohn NM: A population based case-control study of EBV and other viral antibodies among persons with Hodgkin's disease and their siblings. Int J Cancer 34:149-157, 1984.
26. Riddler SA, Breinig MC, McKnight JLC: Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 84:872-984, 1994.
27. Weigel R, Fischer DK, Heston L, Miller G: Constitutive expression of Epstein-Barr virus-encoded RNAs and nuclear antigen during latency and after induction of Epstein-Barr virus replication. J Virol 53:254-259, 1985.